HIF1A and pancreatic neoplasm: A specific inhibitor of TGFß receptor kinase -SB-431542 [110], or HIF-1α -IDF-11774 [111] were shown to efficiently suppress tumor-promoting effects in pancreatic cancer cells and colorectal carcinoma, respectively.